The Real-World Effectiveness of Inactivated COVID-19 Vaccines in Zimbabwe During the Omicron Variant Dominance: A Test-Negative Case–Control Study
This study indicates modest protection from inactivated COVID-19 vaccines against symptomatic Omicron infection, with significant enhancement following booster doses. These findings highlight the need for continued vaccine evaluation, particularly in resource-limited settings, to inform public health strategies and optimize vaccination programs.
Authors
- Patricia Gundidza
- Tariro Makadzange (ORCID: https://orcid.org/0000-0001-5330-1470)
- Chiratidzo E. Ndhlovu (ORCID: https://orcid.org/0000-0001-7863-7974)
- Kimberly Cheryl Chido Konono (ORCID: https://orcid.org/0009-0005-3339-8398)
- Margaret Gurumani
Institutions
- University of Zimbabwe (ZW)
- Family Aids Caring Trust (ZW)
Publication Details
- Journal
- Vaccines
- Published
- 2024-11-22
- DOI
- https://doi.org/10.3390/vaccines12121303
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Coalition for Epidemic Preparedness Innovations
- Medical Research Council